ClinicalTrials.gg

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Program

carboxymethylcellulose

Also written as “Carboxymethylcellulose and Glycerin based artificial tear”, “Optive” and “Carboxymethylcellulose sodium 0.5%, Glycerin 1.0%, Polysorbate 80 0.5%”.

Its studies are mostly in Dry Eye Syndromes · Keratoconjunctivitis Sicca, led by 3 companies.

Drug pageCarboxymethylcellulose: every studyAll 16 studies of it, academic ones too, with its approvals, label and forms.
Furthest: phase 4, since Jul 10, 200910 company-led studies, 1 open or running

Who develops it

Each company that leads studies of it, as its sponsor page counts them.

CompanyStudies it leadsFurthest phaseFirst studyNext primary completion
AbbVieits history only70 open or runningphase 4since Jul 10, 2009Oct 21, 2005none ahead
Innovative Medicalits history only20 open or runningphase 4since Nov 9, 2006Nov 9, 2006none ahead
Andover Research Eye Institute11 open or runningphase 4since Jun 24, 2026Jun 24, 2026none ahead

How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.

History and studies of Andover Research Eye Institute only; the figures above count every company.

History and what’s ahead

From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.

  1. Jun 24, 2026First study: phase 4 study in Dry Eye SyndromesFirst studyNCT07676084 · 60 planned · United States

TargetBeta

Not stated by its company or a source we have read. Most early programs say nothing of it.

Studies

The one study Andover Research Eye Institute leads. Each opens its study page.

StudyPhaseStatusPrimary completionSize
NCT07676084Dry Eye Syndromes · United States4RecruitingOct 202660

How it is read

Names in the registry

  • “Carboxymethylcellulose and Glycerin based artificial tear”, 2 entries
  • “Optive”, 2 entries
  • “Carboxymethylcellulose sodium 0.5%, Glycerin 1.0%, Polysorbate 80 0.5%”, 1 entry
  • “carboxymethylcellulose 0.5%/glycerin 0.9%”, 1 entry
  • “Sodium Carboxymethylcellulose”, 1 entry

Conditions, from the studies’ own filings

First seen by our ledger Nov 13, 2026.

What this can’t show

  • Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
  • Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
  • Primary completion dates are the sponsors’ estimates and often move.
  • A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.